214 related articles for article (PubMed ID: 27862596)
81. Apical rocking is predictive of response to cardiac resynchronization therapy.
Ghani A; Delnoy PP; Ottervanger JP; Misier AR; Smit JJ; Adiyaman A; Elvan A
Int J Cardiovasc Imaging; 2015 Apr; 31(4):717-25. PubMed ID: 25651877
[TBL] [Abstract][Full Text] [Related]
82. Electrophysiological characteristics of ventricular tachyarrhythmias in cardiac sarcoidosis versus arrhythmogenic right ventricular cardiomyopathy.
Dechering DG; Kochhäuser S; Wasmer K; Zellerhoff S; Pott C; Köbe J; Spieker T; Piers SR; Bittner A; Mönnig G; Breithardt G; Wichter T; Zeppenfeld K; Eckardt L
Heart Rhythm; 2013 Feb; 10(2):158-64. PubMed ID: 23070261
[TBL] [Abstract][Full Text] [Related]
83. Implantation feasibility, procedure-related adverse events and lead performance during 1-year follow-up in patients undergoing triple-site cardiac resynchronization therapy: a substudy of TRUST CRT randomized trial.
Lenarczyk R; Kowalski O; Sredniawa B; Pruszkowska-Skrzep P; Mazurek M; Jędrzejczyk-Patej E; Woźniak A; Pluta S; Głowacki J; Kalarus Z
J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1228-36. PubMed ID: 22651239
[TBL] [Abstract][Full Text] [Related]
84. Magnetic resonance imaging for identifying patients with cardiac sarcoidosis and preserved or mildly reduced left ventricular function at risk of ventricular arrhythmias.
Crawford T; Mueller G; Sarsam S; Prasitdumrong H; Chaiyen N; Gu X; Schuller J; Kron J; Nour KA; Cheng A; Ji SY; Feinstein S; Gupta S; Ilg K; Sinno M; Abu-Hashish S; Al-Mallah M; Sauer WH; Ellenbogen K; Morady F; Bogun F
Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1109-15. PubMed ID: 25266311
[TBL] [Abstract][Full Text] [Related]
85. Presence of extensive LV remodeling limits the benefits of CRT in patients with intraventricular dyssynchrony.
Carluccio E; Biagioli P; Alunni G; Murrone A; Pantano P; Biscottini E; Zuchi C; Zingarini G; Cavallini C; Ambrosio G
JACC Cardiovasc Imaging; 2011 Oct; 4(10):1067-76. PubMed ID: 21999865
[TBL] [Abstract][Full Text] [Related]
86. Improvement of the outcome in patients with infantile dilated cardiomyopathy over three decades - The usefulness of long-term gradually medical supportive care.
Tsuda E; Yamada O; Kitano M
J Cardiol; 2019 Aug; 74(2):189-194. PubMed ID: 30876708
[TBL] [Abstract][Full Text] [Related]
87. Clinical Characteristics and Outcomes of Older Cardiac Resynchronization Therapy Recipients Using a Pacemaker versus a Defibrillator.
Munir MB; Althouse AD; Rijal S; Shah MB; Abu Daya H; Adelstein E; Saba S
J Cardiovasc Electrophysiol; 2016 Jun; 27(6):730-4. PubMed ID: 26856440
[TBL] [Abstract][Full Text] [Related]
88. Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation.
Gatzoulis KA; Vouliotis AI; Tsiachris D; Salourou M; Archontakis S; Dilaveris P; Gialernios T; Arsenos P; Karystinos G; Sideris S; Kallikazaros I; Stefanadis C
Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):504-12. PubMed ID: 23588627
[TBL] [Abstract][Full Text] [Related]
89. Potential candidates for cardiac resynchronization therapy in Japanese patients with idiopathic dilated cardiomyopathy--a Niigata multicenter study of DCM--.
Komura S; Chinushi M; Kudo M; Saikawa T; Tanabe Y; Furushima H; Washizuka T; Kodama M; Oda H; Miyajima S; Masani F; Igarashi Y; Murata M; Aizawa Y
Circ J; 2004 Dec; 68(12):1104-9. PubMed ID: 15564691
[TBL] [Abstract][Full Text] [Related]
90. [Impact of cardiac resynchronization therapy on survival in patients with ischemic and nonischemic cardiomyopathy in clinical practice].
Kuznetzov VA; Vinogradova TO; Enina TN; Kolunin GV; Kharatz VE; Pavlov AV; Krinochkin DV; Belonogov DV; Gorbatenko EA; Efimova IuA
Ter Arkh; 2012; 84(8):52-6. PubMed ID: 22994090
[TBL] [Abstract][Full Text] [Related]
91. Assessment of coronary flow reserve predicts long-term outcome of responders to cardiac resynchronization therapy.
Yufu K; Kondo H; Shinohara T; Ishii Y; Yoshimura S; Abe I; Saito S; Fukui A; Okada N; Akioka H; Teshima Y; Nakagawa M; Takahashi N
Heart Vessels; 2019 May; 34(5):763-770. PubMed ID: 30483876
[TBL] [Abstract][Full Text] [Related]
92. Invasive Hemodynamics and Rejection Rates in Patients With Cardiac Sarcoidosis After Heart Transplantation.
Rosenthal DG; Anderson ME; Petek BJ; Arnett DM; Bravo PE; Raghu G; Goldberger ZD; Patton KK; Cheng RK
Can J Cardiol; 2018 Aug; 34(8):978-982. PubMed ID: 30049365
[TBL] [Abstract][Full Text] [Related]
93. Lymph Vessel Proliferation on Cardiac Biopsy May Help in the Diagnosis of Cardiac Sarcoidosis.
Oe Y; Ishibashi-Ueda H; Matsuyama TA; Kuo YH; Nagai T; Ikeda Y; Ohta-Ogo K; Noguchi T; Anzai T
J Am Heart Assoc; 2019 Jan; 8(2):e010967. PubMed ID: 30636545
[TBL] [Abstract][Full Text] [Related]
94. Role of computed tomography-based evaluation of skeletal muscle area in predicting cardiovascular outcomes in patients with chronic heart failure after cardiac resynchronization therapy.
Harada T; Kondo H; Yufu K; Uno A; Takahashi M; Wada M; Yamasaki H; Ogawa N; Takano M; Hirota K; Ishii Y; Yonezu K; Saito S; Fukui A; Akioka H; Shinohara T; Teshima Y; Nakagawa M; Takahashi N
Geriatr Gerontol Int; 2022 Dec; 22(12):1013-1018. PubMed ID: 36271608
[TBL] [Abstract][Full Text] [Related]
95. Clinical Features and Histopathology of Cardiac Sarcoidosis with Refractory Heart Failure: An Autopsy Case.
Terasaki F; Kuwabara H; Takeda Y; Yamauchi Y; Fujita S; Nakamura T; Torii I; Hirose Y; Hoshiga M
Intern Med; 2019 Dec; 58(24):3551-3555. PubMed ID: 31434823
[TBL] [Abstract][Full Text] [Related]
96. Does cardiac resynchronization help patients with cardiac sarcoidosis?
Chicos AB
J Cardiovasc Electrophysiol; 2022 Sep; 33(9):2081-2082. PubMed ID: 35870191
[No Abstract] [Full Text] [Related]
97. Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registries.
Ekström K; Lehtonen J; Nordenswan HK; Mäyränpää MI; Räisänen-Sokolowski A; Kandolin R; Simonen P; Pietilä-Effati P; Alatalo A; Utriainen S; Rissanen TT; Haataja P; Kokkonen J; Vihinen T; Miettinen H; Kaikkonen K; Kerola T; Kupari M
Eur Heart J; 2019 Oct; 40(37):3121-3128. PubMed ID: 31230070
[TBL] [Abstract][Full Text] [Related]
98. Sex and Race Differences in Cardiac Sarcoidosis Presentation, Treatment and Outcomes.
Duvall C; Pavlovic N; Rosen NS; Wand AL; Griffin JM; Okada DR; Tandri H; Kasper EK; Sharp M; Chen ES; Chrispin J; Gilotra NA
J Card Fail; 2023 Aug; 29(8):1135-1145. PubMed ID: 37062472
[TBL] [Abstract][Full Text] [Related]
99. Treatment of cardiac sarcoidosis: A comparative study of steroids and steroids plus immunosuppressive drugs.
Ballul T; Borie R; Crestani B; Daugas E; Descamps V; Dieude P; Dossier A; Extramiana F; van Gysel D; Papo T; Sacre K
Int J Cardiol; 2019 Feb; 276():208-211. PubMed ID: 30527995
[TBL] [Abstract][Full Text] [Related]
100. Outcome of patients with cardiac sarcoidosis undergoing cardiac transplantation--single-center retrospective analysis.
Akashi H; Kato TS; Takayama H; Naka Y; Farr M; Mancini D; Schulze PC
J Cardiol; 2012 Nov; 60(5):407-10. PubMed ID: 22890069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
